BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2529430)

  • 21. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
    Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
    Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extent of metastatic axillary involvement in 1446 cases of breast cancer.
    Veronesi U; Luini A; Galimberti V; Marchini S; Sacchini V; Rilke F
    Eur J Surg Oncol; 1990 Apr; 16(2):127-33. PubMed ID: 2323409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percent positive axillary lymph node metastasis predicts survival in patients with non-metastatic breast cancer.
    Lale Atahan I; Yildiz F; Ozyigit G; Sari S; Gurkaynak M; Selek U; Hayran M
    Acta Oncol; 2008; 47(2):232-8. PubMed ID: 17924207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphoscintigraphic visualization of internal mammary nodes with subtumoral injection of radiocolloid in patients with breast cancer.
    Shimazu K; Tamaki Y; Taguchi T; Motomura K; Inaji H; Koyama H; Kasugai T; Wada A; Noguchi S
    Ann Surg; 2003 Mar; 237(3):390-8. PubMed ID: 12616124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
    Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG
    J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla.
    Hackney L; Williams S; Bajwa S; Morley-Davies AJ; Kirby RM; Britton I
    Breast J; 2013; 19(1):49-55. PubMed ID: 23186153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surface immunoglobulin positive lymphocytes in human breast cancer tissue and homolateral axillary lymph nodes.
    Richters A; Kaspersky CL
    Cancer; 1975 Jan; 35(1):129-33. PubMed ID: 1089036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma.
    Krishnamurthy S; Sneige N; Bedi DG; Edieken BS; Fornage BD; Kuerer HM; Singletary SE; Hunt KK
    Cancer; 2002 Sep; 95(5):982-8. PubMed ID: 12209680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axillary Staging of Early-Stage Invasive Breast Cancer by Ultrasound-Guided Fine-Needle Aspiration Cytology: Which Ultrasound Criteria for Classifying Abnormal Lymph Nodes Should Be Adopted in the Post-ACOSOG Z0011 Trial Era?
    Zhu Y; Zhou W; Zhou JQ; Fei XC; Ye TJ; Huang O; Chen XS; Zhan WW
    J Ultrasound Med; 2016 May; 35(5):885-93. PubMed ID: 27009312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of mast cells in the axillary lymph nodes of breast cancer patients.
    Naik R; Baliga P; Bansal R; Pai M
    J Indian Med Assoc; 1997 Dec; 95(12):606-7. PubMed ID: 9586403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical investigation of axillary lymph nodes for micrometastases in patients with breast cancer using E29.
    Cavaliere A; Falini B; Antonini G
    Tumori; 1989 Dec; 75(6):563-5. PubMed ID: 2617701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.
    Cools-Lartigue J; Sinclair A; Trabulsi N; Meguerditchian A; Mesurolle B; Fuhrer R; Meterissian S
    Ann Surg Oncol; 2013 Mar; 20(3):819-27. PubMed ID: 22972506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
    Kuru B; Bozgul M
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Axillary lymph node metastases in breast cancer. Anatomo-clinical correlation and surgical approach].
    Coroş MF; Stolnicu S; Georgescu R; Roşca A; Sorlea S; Dobre A; Podeanu D; Pălăsan A; Man C; Turcan C
    Chirurgia (Bucur); 2009; 104(5):557-64. PubMed ID: 19943554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Axillary lymph node status, but not tumor size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer.
    Beenken SW; Urist MM; Zhang Y; Desmond R; Krontiras H; Medina H; Bland KI
    Ann Surg; 2003 May; 237(5):732-8; discussion 738-9. PubMed ID: 12724640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.
    Strom EA; Woodward WA; Katz A; Buchholz TA; Perkins GH; Jhingran A; Theriault R; Singletary E; Sahin A; McNeese MD
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1508-13. PubMed ID: 16169678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
    Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
    Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.